Virios therapeutics announces second quarter 2024 financial results

- bateman horne center completed enrollment in its groundbreaking investigator-initiated long-covid phase 2a study featuring valacyclovir and celecoxib (imc-2) -
VIRI Ratings Summary
VIRI Quant Ranking